Philip Felgner Discusses a Malaria Antigen Chip, Pathogen Proteomics | GenomeWeb

At A Glance

Name: Philip Felgner

Position: Professor, Center for Virus Research, University of California, Irvine, since 2002

Chief scientific officer and founder, Gene Therapy Systems, since 1998.

Background: Chief scientist and various other positions, Vical, 1988-98.

Staff scientist, Syntex Research, 1982-88.

Post-doc in biophysics, University of Virginia, 1978-82.

PhD, biochemistry and neuroscience, Michigan State University, 1978.

BS, biochemistry, Michigan State, 1972.


Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.